Orchestra BioMed Holdings (OBIO) Inventory (2022 - 2026)
Orchestra BioMed Holdings (OBIO) posted quarterly Inventory of $277000.0 for Q1 2026, up 105.19% year-over-year from $135000.0 in Q1 2025, and down 10.65% quarter-over-quarter from $310000.0 in Q4 2025.
Powered by 
Analysis
Orchestra BioMed Holdings (OBIO) Inventory (2022 - 2026) Analysis & Trends
Orchestra BioMed Holdings (OBIO) has reported Inventory for 5 consecutive years, with $277000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Inventory rose 105.19% year-over-year to $277000.0; the TTM figure through Mar 2026 stood at $277000.0 (up 105.19% YoY), while the FY2025 annual figure was $310000.0, up 79.19% from the prior year.
- Inventory slipped to $277000.0 in Q1 2026 per OBIO's latest filing, from $310000.0 in the prior quarter.
- Across five years, Inventory topped out at $365000.0 in Q3 2025 and bottomed at $70000.0 in Q2 2024.
- Historically, Inventory has averaged $202357.1 across 5 years, with a median of $181500.0 in 2023.
- Annual changes were most pronounced in 2024 — Inventory sank 60.67% — and 2025, when it jumped 164.29%.
- Orchestra BioMed Holdings' Inventory stood at $276000.0 in 2022, then plunged by 47.1% to $146000.0 in 2023, then gained by 18.49% to $173000.0 in 2024, then soared by 79.19% to $310000.0 in 2025, then retreated by 10.65% to $277000.0 in 2026.
- Business Quant data shows OBIO's Inventory at $277000.0 in Q1 2026, $310000.0 in Q4 2025, and $365000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 280.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 732.60 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 97.11 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 142.38 Mn |
| 10 | Orchestra BioMed Holdings | 322.25 Mn | 127.72 Mn | 63,000.00 | 250,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 250,000.00 |
| Mar 31, 2026 | 277,000.00 |
| Dec 31, 2025 | 310,000.00 |
| Sep 30, 2025 | 365,000.00 |
| Jun 30, 2025 | 185,000.00 |
| Mar 31, 2025 | 135,000.00 |
| Dec 31, 2024 | 173,000.00 |
| Sep 30, 2024 | 234,000.00 |
| Jun 30, 2024 | 70,000.00 |
| Mar 31, 2024 | 115,000.00 |
| Dec 31, 2023 | 146,000.00 |
| Sep 30, 2023 | 137,000.00 |
| Jun 30, 2023 | 178,000.00 |
| Mar 31, 2023 | 232,000.00 |
| Dec 31, 2022 | 276,000.00 |